SEC Form 4 · accession 0001645627-18-000057
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Sep 7, 2018
Accepted (ET)
Sep 11, 2018 · 3:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 7, 2018 | P | 1,000 | $0.0379 | A | 25,895,198 | D | |
| Common Stock | Sep 7, 2018 | P | 1,000 | $0.0368 | A | 25,896,198 | D | |
| Common Stock | Sep 7, 2018 | P | 500 | $0.0382 | A | 25,896,698 | D | |
| Common Stock | Sep 7, 2018 | P | 1,000 | $0.0392 | A | 25,897,698 | D | |
| Common Stock | Sep 7, 2018 | P | 1,000 | $0.0392 | A | 25,898,698 | D | |
| Common Stock | Sep 7, 2018 | P | 1,000 | $0.0382 | A | 25,899,698 | D | |
| Common Stock | Sep 7, 2018 | P | 1,000 | $0.0376 | A | 25,900,698 | D | |
| Common Stock | Sep 7, 2018 | P | 1,000 | $0.0376 | A | 25,901,698 | D | |
| Common Stock | Sep 7, 2018 | P | 1,000 | $0.0376 | A | 25,902,698 | D | |
| Common Stock | Sep 7, 2018 | P | 2,000 | $0.0378 | A | 25,904,698 | D | |
| Common Stock | Sep 7, 2018 | P | 100 | $0.0376 | A | 25,904,798 | D | |
| Common Stock | Sep 7, 2018 | P | 1,000 | $0.038 | A | 25,905,798 | D | |
| Common Stock | Sep 7, 2018 | P | 2,000 | $0.0393 | A | 25,907,798 | D | |
| Common Stock | Sep 7, 2018 | P | 2,000 | $0.0397 | A | 25,909,798 | D |
Table II — derivative securities
No Table II lines on this filing.